CO4700460A1 - 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS - Google Patents

5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS

Info

Publication number
CO4700460A1
CO4700460A1 CO96029521A CO96029521A CO4700460A1 CO 4700460 A1 CO4700460 A1 CO 4700460A1 CO 96029521 A CO96029521 A CO 96029521A CO 96029521 A CO96029521 A CO 96029521A CO 4700460 A1 CO4700460 A1 CO 4700460A1
Authority
CO
Colombia
Prior art keywords
alkyl
hydrogen
cycloalkyl
group
alkoxy
Prior art date
Application number
CO96029521A
Other languages
English (en)
Inventor
Allen Jacob Duplantier
Cooper Kelvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO4700460A1 publication Critical patent/CO4700460A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto de fórmula (I) y sus sales farmacéuticamenteaceptables; en la que R´ es hidrógeno, alquilo de C1 -C6 , alcoxi de C1 -C6 , alquenilo de C2 -C4 , fenilo, dimetilamino, cicloalquilo de C3 -C6 , cicloalquilo de C3 -C6 -alquilo de C1 -C3 o acilo de C1 -C6 , en el que los grupos alquilo, fenilo o alquinilo pueden estar sustituidos con hasta dos grupos hidroxi, alquilo de C1 -C3 o trifluorometilo, o hasta tres halógenos; R2 y R3 se seleccionan cada uno de ellos de forma independiente entre el grupo formado por hidrógeno, alquilo de C1 -C14 , alcoxi de C1 -C7 -alquilo de C1 -C7 , alquenilo de C2 -C14 , cicloalquilo de C3 -C7 , cicloalquilo de C3 -C7 -alquilo de C1 -C2 , un grupo (heterocíclico de C4 -C7 ) - (CH2 )n saturado o insaturado en el que n es 0, 1 ó 2, que contiene como heteroátomos uno o dos del grupo formado por oxígeno, azufre, sulfonilo, nitrógeno y NR4 , en el que R4 es hidrógeno o alquilo de C1 -C4 ; o un grupo de fórmula en el que un entero de 1 a 5; b y c son 0 ó 1; R5 es hidrógeno, hidroxi, alquilo de C1 -C5 , alquenilo de C2 -C5 , alcoxi de C1 -C5 , cicloalcoxi de C3 -C6 , halógeno, trifluorometilo, CO2 R6 , CONR6 R7 , NR6 R7 , NO2 o SO2 NR6 R7 , en el que R6 y R7 son cada uno, de forma independiente hidrógeno o alquilo de C1 -C4 ; en el que Z es oxígeno, azufre, SO2 , CO o NR8 , en el que R8 es hidrógeno o alquilo de C1 -C4 ; e Y es alquileno de C1 -C5 o alquenilo de C2 -C6 opcionalmente sustituido con hasta dos grupos alquilo de C1 -C7 o cicloalquilo de C3 -C7 ; en el que cada uno de dichos grupos alquilo, alquenilo, cicloalquilo, alcoxi-alquilo o heterocíclico puede estar sustituido con uno a catorce, preferiblemente de uno a cinco, del grupo formado por alquilo de C1 -C2 , trifluorometilo o halógeno; y Ra y R10 se seleccionan cada uno de forma independiente entre el grupo formado por hidrógeno, alquilo de C1 -C6 , alcoxi de C1 -C6 , arilo de C6 -C10 y ariloxi de C6 -C10 .
CO96029521A 1995-06-06 1996-06-06 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS CO4700460A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB1995/000429 WO1996039408A1 (en) 1995-06-06 1995-06-06 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
CA002223624A CA2223624C (en) 1995-06-06 1995-06-06 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
HU9601541A HUP9601541A3 (en) 1995-06-06 1996-06-05 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolol[4,3-a]-pyridines and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
CO4700460A1 true CO4700460A1 (es) 1998-12-29

Family

ID=89994031

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96029521A CO4700460A1 (es) 1995-06-06 1996-06-06 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS

Country Status (43)

Country Link
US (1) US6004974A (es)
EP (1) EP0837860B1 (es)
JP (1) JP3107827B2 (es)
KR (2) KR100191972B1 (es)
CN (1) CN1061044C (es)
AP (1) AP609A (es)
AR (1) AR002745A1 (es)
AT (1) ATE214700T1 (es)
AU (1) AU694871B2 (es)
BG (1) BG62568B1 (es)
BR (1) BR9602627A (es)
CA (1) CA2223624C (es)
CO (1) CO4700460A1 (es)
CZ (1) CZ287251B6 (es)
DE (1) DE69525978T2 (es)
DK (1) DK0837860T3 (es)
DZ (1) DZ2044A1 (es)
ES (1) ES2172583T3 (es)
FI (1) FI114097B (es)
HR (1) HRP960268B1 (es)
HU (1) HUP9601541A3 (es)
IL (1) IL118485A (es)
IS (1) IS1913B (es)
LV (1) LV11620B (es)
MA (1) MA23893A1 (es)
MX (1) MX9709897A (es)
MY (1) MY116527A (es)
NO (1) NO306256B1 (es)
NZ (1) NZ286734A (es)
OA (1) OA10458A (es)
PL (1) PL184195B1 (es)
PT (1) PT837860E (es)
RO (1) RO115881B1 (es)
RU (1) RU2161158C2 (es)
SA (1) SA96170065B1 (es)
SG (1) SG54341A1 (es)
SI (1) SI9600186A (es)
SK (1) SK282167B6 (es)
TN (1) TNSN96083A1 (es)
TR (1) TR199600482A1 (es)
TW (1) TW460469B (es)
WO (1) WO1996039408A1 (es)
YU (1) YU49346B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
FR2792938B1 (fr) * 1999-04-28 2001-07-06 Warner Lambert Co NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
EP1380585B1 (en) * 1999-04-30 2004-11-10 Pfizer Products Inc. Pyrazolopyridinone as intermediate
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
US6555572B2 (en) 2000-03-16 2003-04-29 Inflazyme Pharmaceuticals Ltd. Benzylated PDE4 inhibitors
DE60216588T2 (de) * 2001-05-25 2007-09-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kombination eines pde4-inhibitors mit tiotropium zur behandlung obstruktiver atemwegserkrankungen
CN1511042A (zh) * 2001-05-25 2004-07-07 治疗阻塞性气道疾病的pde4抑制剂与抗胆碱能剂的组合
GB0122031D0 (en) * 2001-09-12 2001-10-31 Pfizer Ltd Use of pde4 inhibitors in a dry powder inhaler
GB0129395D0 (en) * 2001-12-07 2002-01-30 Pfizer Ltd Pharmaceutical combination
US20050107420A1 (en) * 2002-05-23 2005-05-19 Boehringe Ingelheim Pharma Gmbh & Co. Kg Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases
WO2006075748A1 (ja) * 2005-01-17 2006-07-20 Santen Pharmaceutical Co., Ltd. アレルギー性結膜疾患治療剤
CA2626612A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
ME01901B (me) 2006-07-05 2014-12-20 Astrazeneca Ab Kombinacija inhibitora HMG-CoA reduktaze atorvastatina ili simvastatina sa fosfodiesteraza 4 inhibitorom, kao što je roflumilast za lečenje inflamatornih pulmonarnih oboljenja
WO2010043676A1 (en) * 2008-10-17 2010-04-22 Boehringer Ingelheim International Gmbh Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor
JP5730896B2 (ja) * 2009-12-04 2015-06-10 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ トリシクロピラゾール誘導体
WO2013084182A1 (en) 2011-12-08 2013-06-13 Glenmark Pharmaceuticals S.A. Pharmaceutical composition that includes a pde4 enzyme inhibitor and an analgesic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697532A (en) * 1970-08-12 1972-10-10 Squibb & Sons Inc 5-methyldipyrazolo {8 3,4-b;3{40 ,4{40 -d{9 {0 pyridin-3(2h)-ones
JP2944048B2 (ja) * 1993-07-06 1999-08-30 フアイザー・インコーポレイテツド 二環式テトラヒドロピラゾロピリジン
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives

Also Published As

Publication number Publication date
PL314459A1 (en) 1996-12-09
AP9600806A0 (en) 1996-07-31
AU5477396A (en) 1996-12-19
IS1913B (is) 2004-02-03
YU49346B (sh) 2005-07-19
AR002745A1 (es) 1998-04-29
AU694871B2 (en) 1998-07-30
US6004974A (en) 1999-12-21
LV11620B (en) 1997-04-20
EP0837860B1 (en) 2002-03-20
RU2161158C2 (ru) 2000-12-27
KR100191972B1 (ko) 1999-06-15
CA2223624A1 (en) 1996-12-12
TW460469B (en) 2001-10-21
YU34696A (sh) 1999-07-28
IL118485A0 (en) 1996-09-12
PL184195B1 (pl) 2002-09-30
CN1061044C (zh) 2001-01-24
KR100225719B1 (en) 1999-10-15
FI114097B (fi) 2004-08-13
NO962320D0 (no) 1996-06-05
BR9602627A (pt) 1998-09-01
NO306256B1 (no) 1999-10-11
AP609A (en) 1997-09-03
MY116527A (en) 2004-02-28
DZ2044A1 (fr) 2002-07-21
JP3107827B2 (ja) 2000-11-13
IL118485A (en) 2000-02-17
EP0837860A1 (en) 1998-04-29
NZ286734A (en) 1998-02-26
MX9709897A (es) 1998-03-31
OA10458A (en) 2002-03-27
HU9601541D0 (en) 1996-07-29
FI974434A (fi) 1997-12-05
PT837860E (pt) 2002-07-31
SA96170065B1 (ar) 2005-12-21
JPH10510242A (ja) 1998-10-06
HRP960268B1 (en) 2002-12-31
CN1142499A (zh) 1997-02-12
MA23893A1 (fr) 1996-12-31
TNSN96083A1 (fr) 2005-03-15
FI974434A0 (fi) 1997-12-05
HRP960268A2 (en) 1997-08-31
SI9600186A (en) 1997-04-30
HUP9601541A2 (en) 1997-02-28
ES2172583T3 (es) 2002-10-01
DK0837860T3 (da) 2002-05-27
TR199600482A1 (tr) 1997-03-21
KR970003440A (ko) 1997-01-28
SK71896A3 (en) 1997-05-07
SG54341A1 (en) 1998-11-16
CA2223624C (en) 2001-02-20
CZ162696A3 (en) 1997-01-15
SK282167B6 (sk) 2001-11-06
DE69525978T2 (de) 2002-12-19
LV11620A (lv) 1996-12-20
BG62568B1 (bg) 2000-02-29
HUP9601541A3 (en) 1997-05-28
ATE214700T1 (de) 2002-04-15
RO115881B1 (ro) 2000-07-28
BG100640A (bg) 1997-03-31
IS4350A (is) 1996-12-07
WO1996039408A1 (en) 1996-12-12
CZ287251B6 (en) 2000-10-11
DE69525978D1 (de) 2002-04-25
NO962320L (no) 1996-12-09

Similar Documents

Publication Publication Date Title
CO4700460A1 (es) 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS
ES2525763T3 (es) Derivados del ácido fenilalcanoico sustituido y sus usos para el tratamiento de enfermedades respiratorias
CO4900032A1 (es) Nuevos derivados de benzamidina
ES2175919T3 (es) Derivados del camptothecin con actividad antitumoral.
CO5560575A2 (es) Compuestos derivados de dihidro-pteridinonas caracterizados por ser inhibidores de especificas cinasas del ciclo celular y preparaciones farmaceuticas que los contienen
CO5640041A2 (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
AR037489A1 (es) Quinolinas sustituidas y proceso para su preparacion
CO5650164A2 (es) Hetrociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
CO5650253A2 (es) Piperazina con grupo fenilo or-sustituido y su uso como inhibidores de glyt1
FI954105A (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
AR042273A1 (es) Derivados de pirazol, procedimiento para prepararlos y las composiciones farmaceuticas que los contienen
AR039222A1 (es) Derivados de quinolina e isoquinolina, un metodo para su preparacion y su uso como inhibidores de la inflamacion
CO5080799A1 (es) Nuevos derivados sustituidos del pirazol
AR050267A1 (es) Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa
ES2567260T3 (es) Inhibidores de la fosfatidilinositol 3-quinasa delta humana
ES2328820T3 (es) Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer.
CO4900056A1 (es) Analogos de indazol sustituidos
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
CO5590924A2 (es) Derivados de indolilalquilamina como ligandos de 5- hidroxitriptamina-6
CO5690582A2 (es) Derivados de n-tiazol-2-il-benzamida
ES2072108T3 (es) Procedimiento de tincion de fibras queratinicas que asocia isatina o uno de sus derivados a una aminopiridina o aminopirimidina, y agentes de tincion.
ES2194683T3 (es) Nuevos derivados siliciados de bencimidazol-benzazoles n-sustituidos o de bezofuranil-benzazoles filtros; composiciones cosmeticas fotoprotectoras que los contienen y utilizacion.
AR008296A1 (es) Compuestos derivados de tetrahidroquinolina, proceso para su preparacion, composiciones que los contienen y su uso en la preparacion de una composicion
CO5040004A1 (es) 2-4-diamino-1,3,5-triazinas, su preparacion y empleo como herbicidas y fitorreguladores
CO4290299A1 (es) Derivados de 1,5-benzodiazepina